The most commonly reported side effects in clinical trials include: Nausea Vomiting Diarrhea Constipation Most of these symptoms were mild to moderate and tended to improve over time as the body adjusted to the medication, especially when doses were increased gradually
Largest Benefits Observed Up to 14.2% weight loss Up to 2.33% HbA1c reduction Superior efficacy compared with semaglutide alone in head-to-head evaluation
Ini yang harus kita cermati, kata Purwantiningsih
Therefore, prospective randomized clinical trials (RCTs) in diverse populations of patients with T2DM and COVID-19 are necessary to assess the potential survival benefits associated with DPP4 inhibition in patients with COVID-19, which might also extend to patients without diabetes mellitus
Subcutaneous administration achieves 7085% bioavailability compared to 4050% for oral routes due to hepatic first-pass metabolism
Each capsule is manufactured in the USA , handled under sterile GMP-aligned conditions, and tested by independent laboratories for purity, identity, and composition